Serum suPAR levels are modulated by immunosuppressive therapy of minimal change nephrotic syndrome

Soluble urokinase-type plasminogen activator receptor (suPAR) could be a causative factor in idiopathic focal segmental glomerulosclerosis (FSGS). It is currently unknown to what extent suPAR levels could be affected by treatment with immunosuppressive drugs such as cyclosporin A (CsA) and mycopheno...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gellermann, Jutta (VerfasserIn) , Schaefer, Franz (VerfasserIn) , Querfeld, Uwe (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 17 August 2014
In: Pediatric nephrology
Year: 2014, Jahrgang: 29, Heft: 12, Pages: 2411-2414
ISSN:1432-198X
DOI:10.1007/s00467-014-2913-5
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00467-014-2913-5
Volltext
Verfasserangaben:Jutta Gellermann, Franz Schaefer, Uwe Querfeld

MARC

LEADER 00000caa a2200000 c 4500
001 1735936790
003 DE-627
005 20220818231624.0
007 cr uuu---uuuuu
008 201019s2014 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00467-014-2913-5  |2 doi 
035 |a (DE-627)1735936790 
035 |a (DE-599)KXP1735936790 
035 |a (OCoLC)1341371242 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Gellermann, Jutta  |e VerfasserIn  |0 (DE-588)1163963054  |0 (DE-627)1028340958  |0 (DE-576)508275571  |4 aut 
245 1 0 |a Serum suPAR levels are modulated by immunosuppressive therapy of minimal change nephrotic syndrome  |c Jutta Gellermann, Franz Schaefer, Uwe Querfeld 
264 1 |c 17 August 2014 
300 |a 4 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 19.10.2020 
520 |a Soluble urokinase-type plasminogen activator receptor (suPAR) could be a causative factor in idiopathic focal segmental glomerulosclerosis (FSGS). It is currently unknown to what extent suPAR levels could be affected by treatment with immunosuppressive drugs such as cyclosporin A (CsA) and mycophenolate mofetil (MMF). Treatment with CsA, but not MMF, is accompanied by nephrotoxicity, and since suPAR levels correlate with glomerular filtration rate (GFR), treatment with these drugs could indirectly modulate suPAR levels by their effect on renal function. 
700 1 |a Schaefer, Franz  |d 1961-  |e VerfasserIn  |0 (DE-588)1023365383  |0 (DE-627)718365577  |0 (DE-576)366705598  |4 aut 
700 1 |a Querfeld, Uwe  |e VerfasserIn  |0 (DE-588)107222786X  |0 (DE-627)827058098  |0 (DE-576)171252152  |4 aut 
773 0 8 |i Enthalten in  |t Pediatric nephrology  |d Berlin : Springer, 1987  |g 29(2014), 12, Seite 2411-2414  |h Online-Ressource  |w (DE-627)254638872  |w (DE-600)1463004-7  |w (DE-576)074531689  |x 1432-198X  |7 nnas  |a Serum suPAR levels are modulated by immunosuppressive therapy of minimal change nephrotic syndrome 
773 1 8 |g volume:29  |g year:2014  |g number:12  |g pages:2411-2414  |g extent:4  |a Serum suPAR levels are modulated by immunosuppressive therapy of minimal change nephrotic syndrome 
856 4 0 |u https://doi.org/10.1007/s00467-014-2913-5  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201019 
993 |a Article 
994 |a 2014 
998 |g 1023365383  |a Schaefer, Franz  |m 1023365383:Schaefer, Franz  |d 910000  |d 910500  |d 50000  |e 910000PS1023365383  |e 910500PS1023365383  |e 50000PS1023365383  |k 0/910000/  |k 1/910000/910500/  |k 0/50000/  |p 2 
999 |a KXP-PPN1735936790  |e 3781853330 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Gellermann, Jutta","family":"Gellermann","given":"Jutta","role":"aut","roleDisplay":"VerfasserIn"},{"display":"Schaefer, Franz","family":"Schaefer","given":"Franz","role":"aut","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","role":"aut","given":"Uwe","family":"Querfeld","display":"Querfeld, Uwe"}],"relHost":[{"id":{"zdb":["1463004-7"],"eki":["254638872"],"issn":["1432-198X"]},"disp":"Serum suPAR levels are modulated by immunosuppressive therapy of minimal change nephrotic syndromePediatric nephrology","physDesc":[{"extent":"Online-Ressource"}],"part":{"pages":"2411-2414","issue":"12","extent":"4","volume":"29","text":"29(2014), 12, Seite 2411-2414","year":"2014"},"origin":[{"dateIssuedKey":"1987","publisher":"Springer ; Springer","dateIssuedDisp":"1987-","publisherPlace":"Berlin ; Heidelberg ; Berlin ; Heidelberg ; New York, NY"}],"note":["Gesehen am 06.12.05"],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1987 -"],"title":[{"subtitle":"journal of the International Pediatric Nephrology Association","title_sort":"Pediatric nephrology","title":"Pediatric nephrology"}],"recId":"254638872","language":["eng"]}],"id":{"doi":["10.1007/s00467-014-2913-5"],"eki":["1735936790"]},"recId":"1735936790","language":["eng"],"title":[{"title_sort":"Serum suPAR levels are modulated by immunosuppressive therapy of minimal change nephrotic syndrome","title":"Serum suPAR levels are modulated by immunosuppressive therapy of minimal change nephrotic syndrome"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 19.10.2020"],"origin":[{"dateIssuedDisp":"17 August 2014","dateIssuedKey":"2014"}],"physDesc":[{"extent":"4 S."}],"name":{"displayForm":["Jutta Gellermann, Franz Schaefer, Uwe Querfeld"]}} 
SRT |a GELLERMANNSERUMSUPAR1720